Table 4 Clinicopathological parameters and responses to chemotherapy with urine TFF3 in colorectal cancer patients

Age

 ≤60

37

5.71 ± 0.94

0.088

 >60

20

3.99 ± 0.89

Gender

 Male

37

5.17 ± 0.93

0.558

 Female

20

6.04 ± 1.03

Site

 Colon

38

4.84 ± 0.64

0.201

 Rectum

19

6.75 ± 1.66

Degree of differentiation

 Well-moderately

47

5.67 ± 0.84

0.558

 Poorly

10

4.58 ± 0.56

Stage

(I-III VS IV)

0.222

 I-II

9

3.72 ± 1.16

 III

11

4.60 ± 1.58

 IV

37

6.16 ± 0.92

Lymphatic metastasis

 N(-)

9

2.92 ± 1.00

0.164

 N(+)

14

5.57 ± 1.32

Distant metastasis

 M0

20

4.20 ± 0.99

0.184

Responses to chemotherapy

 PR

8

  Befor-chemo

9.18 ± 3.06

0.076

  After-chemo

3.06 ± 0.93

 SD

17

  Befor-chemo

5.95 ± 1.16

0.76

  After-chemo

8.83 ± 3.35

 PD

4

  Befor-chemo

3.26 ± 0.87

0.13

  After-chemo

9.87 ± 3.68